Cargando…
Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer
SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is associated with a poor prognosis, and the development of better therapeutic strategies is required. Herein, we investigated the role of the anti-angiogenic thrombospondin-1 (TSP1) in TNBC. TSP1 expression in tumor biopsies from TNBC patients wa...
Autores principales: | Marcheteau, Elie, Farge, Thomas, Pérès, Michaël, Labrousse, Guillaume, Tenet, Julie, Delmas, Stéphanie, Chusseau, Maud, Duprez-Paumier, Raphaëlle, Franchet, Camille, Dalenc, Florence, Imbert, Caroline, Noujarède, Justine, Colacios, Céline, Prats, Hervé, Cabon, Florence, Ségui, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391594/ https://www.ncbi.nlm.nih.gov/pubmed/34439212 http://dx.doi.org/10.3390/cancers13164059 |
Ejemplares similares
-
Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast Cancer
por: Franchet, Camille, et al.
Publicado: (2021) -
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
por: Bertrand, Florie, et al.
Publicado: (2017) -
Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study
por: Sarradin, Victor, et al.
Publicado: (2021) -
TNF-R1, an immune checkpoint in melanoma?
por: Bertrand, Florie, et al.
Publicado: (2015) -
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
por: Imbert, Caroline, et al.
Publicado: (2020)